MOH Policy and Guidelines for Health Institutions
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
Vulnerable and Marginalized Groups Planning Framework
Transforming health: Acclerating the attainment of health goals
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
The full report you can download under
https://reliefweb.int/sites/reliefweb.int/files/resources/pdna_report_mozambique_cyclone_idai.pdf
(Large File 11 MB)
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.
Learning from earthquake relief and recovery operations
Transforming the Quality of Health Care in Ethiopia
A training course for Vasectomy Providers and Assistants
2nd Edition
Primary Care: The Community Health System
National Tuberculosis and Leprosy Conrol Programme
A guide to support implementation of health service Quality Improvement activities in Ethiopian health facilities
English Manual and Guideline on World about Food and Nutrition, Health and Epidemic; published on 30 Nov 2021 by USAID
Briefing Note no. 80 November 2015
Transformation and outlook
GGGI Technical Guideline No. 2
Sector Environmental Guidelines, Full technical Update
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
more